Paranovus Entertainment Technology PAVS · USD
Consumer Staples · US listing · 🇺🇸 United States
2.81
-14.33%
Close of 5 Nov 2026, in USD
About Paranovus Entertainment Technology
Its shares trade under the ticker PAVS. It has been listed since 25 October 2019. In the fiscal year to 31 March 2026, it reported revenue of $14.6m and a net loss of $12.7m. At that date it held total assets of $36.9m and shareholders' equity of $31.2m.
Paranovus Entertainment Technology Ltd. engages in the research, development, manufacture, and sale of nutraceutical and dietary supplement products in the People's Republic of China and internationally. The company is headquartered in Nanping, Fujian. The company went IPO on 2019-10-25. The firm's main businesses are the research and development, manufacturing and sales of nutritional products made from traditional Chinese medicine and animal extracts. The firm's main products include spore powder, cordyceps mycelium products, donkey-hide gelatin solution products, vitamins and dietary supplement products, American ginseng products and other nutrition products. The firm also engages in e-commerce and auto sales through the platforms Happy Buy and Taochejun.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Consumer Staples
- Industry
- Personal Care Products
- Listed since
- 25 Oct 2019
- Employees
- 80
- Website
- happ.org.cn ↗
- Head office
- 1177 6TH AVENUE, 5TH FLOOR, NEW YORK, NY, 10036
- Incorporated in
- E9
- Classification
- Services-Computer Processing & Data Preparation
- Filer status
- Non-accelerated filer
Leadership
Pay as last reported
- Mr. Xuezhu WangChairman of the Board, Chief Executive Officer, since 2018$53,483
- Mr. Jiong BianChief Financial Officer$33,507
- Mr. Wenhui LinVice General Manager, Director, since 2007$29,635
- Mr. Zhangshu HuangIndependent Director$5,400
- Mr. Lun LiuIndependent Director$50,640
- Mr. Yijian XuIndependent Director
- Ping ChenIR Contact Officer, since 2022
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Paranovus Entertainment Technology Ltd. focuses on traditional Chinese medicine-based nutraceuticals in China.
- The company's main products include spore powder and cordyceps mycelium for health supplements.
- Paranovus employs 80 full-time staff with a strong focus on research and development.
Weaknesses
- The company operates primarily in the People's Republic of China with limited international presence.
- Paranovus has no e-commerce platforms beyond Happy Buy and Taochejun for auto sales.
- The firm's business is concentrated on nutraceuticals without diversification into other sectors.
Opportunities
- Expanding e-commerce through Happy Buy and Taochejun could increase international sales.
- Growing demand for traditional Chinese medicine products in global markets offers potential.
- Increasing consumer interest in dietary supplements presents new market opportunities.
Threats
- Competition from established nutraceutical companies in China may impact market share.
- Regulatory changes in the People's Republic of China could affect product approvals.
- Economic downturns might reduce consumer spending on dietary supplements.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.